Close Menu
Home » Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech

Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech

Nov 27, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Precipio said today that the University of Cincinnati Medical Center (UCMC) will use its ICE-COLD PCR (ICP) mutation enrichment technology in a study screening for clinically actionable mutations in non-small cell lung cancer (NSCLC) patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Add the Missing Data

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, SciencenInsider reports.

Two Red Panda Species

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

Kit Fix

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

Nature Papers Explore Epigenetic Factors in Aging, Gene Loss in Animal Kingdom

In Nature this week: epigenetic factors that prevent healthy aging and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health to Focus on Early Cancer Detection and Monitoring, CDx Development in 2020

    Premium

  2. BioMérieux Reports 11 Percent Revenue Growth in Q4

  3. Co-Diagnostics SARS-CoV-2 Assay Garners CE Mark

  4. NanoString Technologies Q4 Revenues Up 23 Percent

  5. Natera Q4 Revenues Rise 24 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.